ARK Investment Management - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$107,338,401
+8.0%
2,366,367
-2.3%
0.82%
+24.8%
Q2 2023$99,400,562
+5.5%
2,422,631
-8.1%
0.66%
+1.5%
Q1 2023$94,253,242
-6.7%
2,637,192
-1.4%
0.65%
-25.9%
Q4 2022$100,979,530
-38.5%
2,673,538
-28.0%
0.88%
-23.6%
Q3 2022$164,231,000
-4.3%
3,713,107
-21.0%
1.14%
+12.8%
Q2 2022$171,691,000
-24.9%
4,701,297
-23.8%
1.02%
+6.4%
Q1 2022$228,585,000
+6.1%
6,171,308
-12.9%
0.95%
+46.3%
Q4 2021$215,543,000
-24.5%
7,083,256
-16.8%
0.65%
-5.0%
Q3 2021$285,472,000
-19.7%
8,511,384
-4.4%
0.69%
+3.8%
Q2 2021$355,329,000
+53.7%
8,907,733
+73.2%
0.66%
+44.0%
Q1 2021$231,197,000
+70.4%
5,142,271
+114.3%
0.46%
+27.1%
Q4 2020$135,671,000
+468.9%
2,399,554
+377.5%
0.36%
+156.0%
Q3 2020$23,846,000
+17.5%
502,560
+46.0%
0.14%
-35.3%
Q2 2020$20,290,000
+258.5%
344,131
+187.5%
0.22%
+54.6%
Q1 2020$5,659,000
-56.6%
119,681
-44.6%
0.14%
-57.1%
Q4 2019$13,050,000
+10.8%
216,025
+9.8%
0.33%
+28.0%
Q3 2019$11,782,000
+16.2%
196,669
+24.7%
0.26%
+0.8%
Q2 2019$10,140,000
-24.3%
157,773
-4.4%
0.26%
-33.4%
Q1 2019$13,391,000
+2.2%
164,978
-31.9%
0.38%
-28.0%
Q4 2018$13,099,000
+10.7%
242,312
+5.7%
0.53%
+49.0%
Q3 2018$11,828,000
+33.2%
229,318
+7.6%
0.36%
+9.8%
Q2 2018$8,881,000
-42.7%
213,127
-39.4%
0.32%
-57.8%
Q1 2018$15,512,000
-16.8%
351,905
-5.1%
0.77%
-48.2%
Q4 2017$18,653,000
+107.2%
370,835
+109.5%
1.49%
-15.2%
Q2 2017$9,004,000
+75.6%
176,991
+38.7%
1.75%
+18.6%
Q1 2017$5,128,000
+1517.7%
127,563
+1826.6%
1.48%
+1185.2%
Q4 2016$317,0006,6210.12%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
BB BIOTECH AG 6,913,172$330,657,00012.25%
TANAKA CAPITAL MANAGEMENT INC 84,953$4,063,0009.51%
Sicart Associates LLC 280,315$13,407,0009.26%
DOWLING & YAHNKE LLC 675,843$32,326,0003.62%
Opus Point Partners Management, LLC 77,550$3,709,0002.96%
Motley Fool Asset Management LLC 259,000$12,388,0002.75%
Motley Fool Wealth Management, LLC 333,604$15,956,0001.70%
ALTRINSIC GLOBAL ADVISORS LLC 921,174$44,060,0001.63%
PINNACLE ASSOCIATES LTD 1,572,045$75,191,0001.52%
Sonora Investment Management, LLC 121,703$5,821,054,0001.20%
View complete list of IONIS PHARMACEUTICALS INC shareholders